Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies
figure
posted on 2020-04-20, 14:47 authored by Timothy Smith, John H Krege, Suchitrita S Rathmann, Sherie A Dowsett, Ann Hake, Emel SM Nery, Brandy R Matthews, Erin G Doty<p>The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
©
The authors, CC-BY-NC 2020.<b></b>
Funding
CoLucid Pharmaceuticals, a subsidiary of Eli Lilly and Company.
History
Related Materials
- 1.
- 2.
